中国P站

Congenital Anomalies; Global Burden of Disease; Prenatal Diagnosis; Genomic Sequencing; Fetal Therapy; Genetic Counseling; Environmental Risk Factors; Maternal Nutrition; Public Health; Neurodevelopmental Outcomes

Introduction

This systematic analysis from the Global Burden of Disease Study 2019 quantifies the global burden of 20 categories of congenital anomalies, revealing persistent high disability-adjusted life-years (DALYs) and mortality, particularly in low-income regions. The study provides critical insights into the epidemiological trends over three decades, underscoring the urgent need for targeted public health interventions, improved surveillance, and enhanced access to care to mitigate the significant impact of these conditions worldwide[1].

This review offers an updated perspective on the capabilities and limitations of non-invasive prenatal testing (NIPT) for detecting a broad spectrum of congenital anomalies beyond common aneuploidies. It discusses recent advancements in NIPT technology, its expanding clinical applications, and the challenges in interpreting results for rare conditions. The article highlights the importance of genetic counseling and integrated care pathways for managing positive NIPT findings and ensuring informed reproductive choices[2].

This Pediatric Heart Network study provides an updated understanding of neurodevelopmental outcomes in children with congenital heart disease, emphasizing the high prevalence of developmental challenges across cognitive, motor, and behavioral domains. The research highlights the critical need for early and ongoing screening, specialized interventions, and multidisciplinary care approaches to optimize long-term outcomes and improve quality of life for these vulnerable patients[3].

This review explores significant advancements in fetal diagnosis and therapeutic interventions for a range of congenital anomalies. It covers improvements in imaging technologies, genetic testing, and innovative fetal surgical techniques that now allow for earlier and more precise diagnoses, alongside effective in-utero treatments. The article emphasizes the evolving multidisciplinary approach to managing complex fetal conditions, aiming to improve perinatal outcomes and reduce long-term morbidity[4].

This review delves into recent advances in the molecular genetics underlying congenital anomalies of the kidney and urinary tract (CAKUT), a leading cause of end-stage kidney disease in children. It discusses the identification of novel genes, the utility of next-generation sequencing, and the complex genetic architecture involving monogenic and polygenic factors. The article emphasizes how these genetic insights are paving the way for improved diagnostic strategies, risk stratification, and potentially personalized therapeutic approaches for CAKUT[5].

This article updates our understanding of environmental risk factors contributing to congenital anomalies, reviewing various exposures including maternal infections, medications, toxins, and nutritional deficiencies. It emphasizes the complex interplay between genetic predispositions and environmental triggers, highlighting critical periods of vulnerability during embryonic and fetal development. The review stresses the importance of preconception care, public health campaigns, and careful risk assessment to minimize preventable congenital conditions[6].

This review outlines global public health priorities for congenital anomalies, emphasizing the need for comprehensive strategies that encompass surveillance, primary prevention, early diagnosis, and access to care. It discusses the effectiveness of folic acid fortification, rubella vaccination, and pre-conception counseling as key preventive measures. The article advocates for stronger public health policies and collaborative efforts to reduce the global burden and improve outcomes for affected individuals, particularly in resource-limited settings[7].

This contemporary review explores the complex ethical landscape surrounding prenatal diagnosis of congenital anomalies, addressing issues such as informed consent, reproductive autonomy, the potential for selective abortion, and the evolving capabilities of genomic technologies. It highlights the importance of comprehensive genetic counseling that respects diverse cultural and personal values, and advocates for balanced information provision to support parents in making deeply personal and ethical decisions regarding their pregnancy[8].

This systematic review evaluates the clinical utility of genomic sequencing, including whole-exome and whole-genome sequencing, in diagnosing congenital anomalies in children. It highlights the significant diagnostic yield of these technologies, especially in cases where conventional genetic testing has been inconclusive. The review emphasizes how genomic sequencing can provide definitive diagnoses, guide clinical management, and facilitate genetic counseling for affected families, thereby transforming the diagnostic odyssey for complex congenital conditions[9].

This review synthesizes current evidence on the relationship between maternal nutrition and the risk of congenital anomalies, examining the roles of specific micronutrients like folic acid, iodine, and vitamin D, as well as overall dietary patterns. It highlights how nutritional deficiencies or excesses during critical windows of periconceptional development can significantly impact fetal health. The article advocates for enhanced maternal nutritional counseling, supplementation strategies, and public health interventions to promote optimal maternal health and reduce the incidence of preventable birth defects globally[10].

Description

Congenital anomalies impose a significant global burden, marked by high disability-adjusted life-years (DALYs) and mortality, particularly impacting low-income regions. Insights into these epidemiological trends over three decades highlight the urgent need for targeted public health interventions, enhanced surveillance, and improved access to care globally [1]. Public health priorities specifically advocate for comprehensive strategies encompassing primary prevention, early diagnosis, and access to care. Effective preventive measures include folic acid fortification, rubella vaccination, and pre-conception counseling. Stronger public health policies and collaborative efforts are crucial to reduce this global burden and improve outcomes, especially in resource-limited settings [7].

Recent advancements in prenatal and postnatal diagnostics are revolutionizing the identification of congenital anomalies. Non-invasive prenatal testing (NIPT) offers an updated perspective on detecting a broad spectrum of congenital anomalies beyond common aneuploidies, necessitating robust genetic counseling and integrated care pathways for managing positive findings and ensuring informed reproductive choices [2]. Furthermore, significant progress has been made in fetal diagnosis and therapeutic interventions, with improvements in imaging technologies, genetic testing, and innovative fetal surgical techniques enabling earlier and more precise diagnoses alongside effective in-utero treatments. This evolving multidisciplinary approach aims to improve perinatal outcomes and reduce long-term morbidity [4]. For children with complex or undiagnosed conditions, genomic sequencing, including whole-exome and whole-genome sequencing, demonstrates significant clinical utility by providing high diagnostic yields, guiding clinical management, and facilitating genetic counseling for affected families [9].

The molecular genetics underlying specific conditions like congenital anomalies of the kidney and urinary tract (CAKUT), a leading cause of end-stage kidney disease in children, have seen recent advances. Identification of novel genes and understanding complex genetic architectures involving monogenic and polygenic factors are paving the way for improved diagnostic strategies, risk stratification, and personalized therapeutic approaches [5]. Beyond genetics, environmental risk factors also play a critical role. Exposures such as maternal infections, medications, toxins, and nutritional deficiencies, interacting with genetic predispositions, highlight critical periods of vulnerability during embryonic and fetal development. This underscores the importance of preconception care, public health campaigns, and careful risk assessment to minimize preventable congenital conditions [6].

Maternal nutrition is a key area of focus, with current evidence linking specific micronutrients like folic acid, iodine, and vitamin D, as well as overall dietary patterns, to the risk of congenital anomalies. Deficiencies or excesses during periconceptional development can significantly impact fetal health, advocating for enhanced maternal nutritional counseling, supplementation strategies, and public health interventions to promote optimal maternal health [10]. Alongside medical and scientific progress, ethical considerations in prenatal diagnosis of congenital anomalies are paramount. Issues like informed consent, reproductive autonomy, the potential for selective abortion, and the capabilities of genomic technologies require comprehensive genetic counseling that respects diverse cultural and personal values, ensuring balanced information for deeply personal decisions [8].

Optimizing long-term outcomes for children affected by congenital anomalies is a vital aspect of comprehensive care. For instance, children with congenital heart disease often face a high prevalence of neurodevelopmental challenges across cognitive, motor, and behavioral domains. Recognizing this, there is a critical need for early and ongoing screening, specialized interventions, and multidisciplinary care approaches to improve quality of life for these vulnerable patients [3].

Conclusion

The global burden of congenital anomalies remains substantial, with significant disability-adjusted life-years (DALYs) and mortality, especially in low-income regions. There is an urgent need for targeted public health interventions, improved surveillance, and enhanced access to care worldwide. Advancements in diagnostic capabilities are transforming the management of these conditions. Non-invasive prenatal testing (NIPT) is expanding beyond common aneuploidies to detect a broader spectrum of anomalies, emphasizing the importance of genetic counseling for informed reproductive choices. Fetal diagnosis has seen remarkable progress with improved imaging, genetic testing, and innovative fetal surgical techniques, allowing for earlier, more precise diagnoses and effective in-utero treatments, aiming to improve perinatal outcomes. Genomic sequencing, including whole-exome and whole-genome sequencing, offers a significant diagnostic yield for complex congenital conditions in children, providing definitive diagnoses and guiding clinical management, especially when conventional testing is inconclusive. For specific anomalies like congenital anomalies of the kidney and urinary tract (CAKUT), molecular genetics research is identifying novel genes and complex genetic architectures, paving the way for personalized diagnostic and therapeutic approaches. Understanding risk factors is crucial for prevention. Environmental exposures such as maternal infections, medications, toxins, and nutritional deficiencies, alongside genetic predispositions, play a complex role. Maternal nutrition, particularly the roles of micronutrients like folic acid, iodine, and vitamin D, during periconceptional development, significantly impacts fetal health. This highlights the importance of preconception care, nutritional counseling, and public health campaigns. Public health strategies globally prioritize surveillance, primary prevention, early diagnosis, and access to care, with folic acid fortification and rubella vaccination being effective measures. Addressing the ethical landscape of prenatal diagnosis, including informed consent and reproductive autonomy, is paramount, requiring comprehensive genetic counseling that respects diverse values. Ultimately, optimizing long-term outcomes for affected children, such as those with congenital heart disease who face neurodevelopmental challenges, demands early screening, specialized interventions, and multidisciplinary care.

References

1. Mohsen MEAE, Mohammed AE, Reem A (2021) .Lancet Glob Health 9:e1547-e1564.

   , ,

2. Peter B, Karen JC, Stephen JG (2021) .Prenat Diagn 41:1615-1627.

   , ,

3. Karen U, Amy C, Nadine AP (2021) .Pediatrics 148:e2020025964.

   , ,

4. Aaron BC, Jessica JC, Ajay JK (2020) .Am J Obstet Gynecol 222:S888-S900.

   , ,

5. Simone S, Rachel W, Gian MG (2021) .J Am Soc Nephrol 32:1324-1339.

   , ,

6. Maria-Regina O, Katja B, Ulrich G (2020) .Geburtshilfe Frauenheilkd 80:569-580.

   , ,

7. Alberto R, Tally L, T. YK (2020) .Best Pract Res Clin Obstet Gynaecol 62:70-80.

   , ,

8. Willy R, Lyn SC, Seema C (2021) .Eur J Hum Genet 29:161-171.

   , ,

9. Lin M, Yi M, Xiaoxiao C (2021) .Hum Genet 140:1541-1555.

   , ,

10. Hannah B, Simon C, Navdeep K (2020) .Matern Child Health J 24:1259-1269.

    , ,